News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
206 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (3067)
February (2725)
March (2858)
April (2936)
May (3736)
June (2836)
July (2951)
August (2835)
September (2998)
October (3624)
November (3299)
December (2403)
Day
2 (165)
3 (175)
4 (151)
5 (147)
6 (92)
9 (206)
10 (178)
11 (131)
12 (134)
13 (90)
16 (130)
17 (134)
18 (124)
19 (139)
20 (123)
23 (88)
27 (84)
30 (66)
31 (46)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
16
17
18
19
20
23
27
30
31
Drug Development
Sunovion Pharmaceuticals Inc. Presents Positive Results From Two Phase 3 Studies Of Once-Daily Aptiom® (Eslicarbazepine Acetate) As Monotherapy Treatment For Partial-Onset Seizures
December 9, 2013
·
1 min read
Drug Development
Emergent BioSolutions Presents Positive Interim Phase 2 Data Evaluating Otlertuzumab (TRU-016) In Combination With Bendamustine In People With Relapsed Chronic Lymphocytic Leukemia
December 9, 2013
·
1 min read
Argenta Discovery Inc. Announces Record Year For Peer-Reviewed Publications
December 9, 2013
·
2 min read
Sequenta, Inc.'s ClonoSIGHT MRD Test Can Detect Relapse Of Diffuse Large B-Cell Lymphoma More Than Seven Months Before CT Scan
December 9, 2013
·
1 min read
Biotech Bay
Nora Therapeutics Announces New Time For Presentation At The Oppenheimer 24th Annual Healthcare Conference
December 9, 2013
·
1 min read
Business
Regado Biosciences, Inc. Strengthens Executive Leadership
December 9, 2013
·
3 min read
Business
ThromboGenics NV’ Founder Prof Desire Collen Retiring As Chairman
December 9, 2013
·
1 min read
Genetown
Selecta Biosciences, Inc. Announces Allowance Of The First In A Series Of Patents On The Induction Of Antigen-Specific Immune Tolerance Using Selecta’s Novel Immunotherapies
December 9, 2013
·
1 min read
Drug Development
Immunomedics, Inc. Reports Promising Activity With Veltuzumab In Relapsed Immune Thrombocytopenia
December 9, 2013
·
1 min read
Business
Aurinia (Formerly Known as Isotechnika Pharma Inc.) Announces Change To Board Of Directors
December 9, 2013
·
1 min read
Previous
14 of 21
Next
